At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 12 enrolled
Drug / intervention
Minocyclinedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Administration of Oral Extended Release Minocycline for Assessment of Skin and Plasma Concentrations of Minocycline
In Brief
A Phase 4 clinical trial evaluating Minocycline for Acne. Completed, enrolled 12 participants across 1 site.
Detailed Summary
The primary objective of this study is to evaluate the skin and plasma concentrations of minocycline in subjects undergoing treatment of acne vulgaris with oral extended release minocycline. Acne lesion counts and safety/tolerance of the treatment will also be evaluated.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20162017201820192020202120222023202420252026
First PostedMar 2016
Enrollment StartMar 2016
Primary CompletionApr 2016
Study CompletionMay 2016
TodayJul 2026
First PostedMar 1, 2016
Enrollment StartMar 1, 2016
Primary CompletionApr 1, 2016
Study CompletionMay 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 10.3 years ago
Interventions
Minocyclinedrug
Oral extended release minocycline